Literature DB >> 9449946

Pneumococci causing invasive disease in Britain 1982-1990.

G Colman1, E M Cooke, B D Cookson, P G Cooper, A Efstratiou, R C George.   

Abstract

A total of 5348 isolates of Streptococcus pneumoniae was serotyped and screened for insusceptibility to tetracycline, penicillin, erythromycin and chloramphenicol. Of these, 4238 (79%) were isolated from patients who had pneumonia or meningitis or were bacteraemic. Altogether, 3948 (74%) of the isolates belonged to one or other of the serotypes 1, 3, 4, 6, 8, 9, 14, 19 or 23 with serotypes 6, 14, 18, 19 and 23 being frequent causes of invasive disease in young children. Many isolates of type 1 were isolated from pneumonia and few from meningitis. Some 768 (14%) isolates were insusceptible to one or more antibiotic and 591 of these belonged to serotypes 6, 9, 14, 19 or 23. Representatives of type 14 resistant to erythromycin were prominent from 1986 onwards. There was an increase in the number of multi-resistant pneumococci from 1985. Among these were isolates of type 23 insusceptible to penicillin, chloramphenicol and tetracycline and cultures of type 6 resistant additionally to erythromycin.

Entities:  

Mesh:

Year:  1998        PMID: 9449946     DOI: 10.1099/00222615-47-1-17

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Evaluation of semiautomated multiplex PCR assay for determination of Streptococcus pneumoniae serotypes and serogroups.

Authors:  Elliot R Lawrence; David B Griffiths; Siobhán A Martin; Robert C George; Lucinda M C Hall
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.

Authors:  Andreas Kronenberg; Phillip Zucs; Sara Droz; Kathrin Mühlemann
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Evaluation of serotype prediction by cpsA-cpsB gene polymorphism in Streptococcus pneumoniae.

Authors:  E R Lawrence; C A Arias; B Duke; D Beste; K Broughton; A Efstratiou; R C George; L M Hall
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Outcome of invasive pneumococcal disease: a UK based study. Oxford Pneumococcal Surveillance Group.

Authors:  F Shackley; K Knox; J B Morris; D Crook; D Griffiths; R Mayon-White; R George; L Willocks; E Moxon
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

5.  Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance.

Authors:  Helle Bossen Konradsen; Margit Staum Kaltoft
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae.

Authors:  N Doherty; K Trzcinski; P Pickerill; P Zawadzki; C G Dowson
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

7.  Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates.

Authors:  Melissa M Daly; Stella Doktor; Robert Flamm; Dee Shortridge
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.

Authors:  P Ispahani; R C B Slack; F E Donald; V C Weston; N Rutter
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

9.  Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005.

Authors:  C A Ihekweazu; D A B Dance; R Pebody; R C George; M D Smith; P Waight; H Christensen; K A V Cartwright; J M Stuart
Journal:  Epidemiol Infect       Date:  2007-10-26       Impact factor: 2.451

10.  Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland.

Authors:  D Bennett; B Lennon; H Humphreys; M Cafferkey
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.